توضیحاتی در مورد کتاب :
سرطان سر و گردن (HNC) یک گروه ناهمگن از سرطان ها است که در صورت ترکیب، یکی از شایع ترین انواع سرطان را نشان می دهد. بیماران مبتلا به HNC به دلیل اهمیت ساختارهای درگیر از عوارض و مرگ و میر قابل توجهی رنج می برند. بیش از دو سوم از این بیماران در مراحل پایانی تشخیص داده می شوند که منجر به پیش آگهی ضعیف می شود. بنابراین، پیشرفت در تشخیص و درمان زودرس HNC بسیار مهم است. این جلد دوم یک مرور کلی به روز از پیشینه نظری در زمینه سرطان سر و گردن (HNC) و همچنین تحقیقات نوظهوری که بر درک ما از این بیماری تأثیر می گذارد ارائه می دهد. کتاب با بررسی جامع اپیدمیولوژی، علت شناسی، علائم، تشخیص و مرحله HNC آغاز می شود. در مرحله بعد، موارد ضروری اختلالات بدخیم بالقوه حفره دهان، انواع مهم HNC را پوشش می دهد. متعاقباً، تحقیقات تازه در حال ظهور در زمینه HNC را پوشش می دهد. هدف کلی تغییر به سمت پزشکی دقیق است (که در جلد اول به تفصیل مورد بحث قرار گرفته است)، که مزایای بالینی فردی را برای بیماران مبتلا به HNC به ارمغان خواهد آورد. این جلد دوم از تشخیص و درمان زودهنگام سرطانهای سر و گردن با موضوع درد مزمن مرتبط با HNC، شامل مکانیسمهای درد و استراتژیهای مدیریت، و رویکرد دارورسانی مخاط چسب خوراکی در حال ظهور برای HNC، به پایان میرسد. همه جراحان HNC، دانشمندان، دستیاران و افرادی که زندگی آنها تحت تأثیر این بیماری قرار گرفته است، تأثیر درد بر سلامت بیمار و مسیر بهبودی او را تشخیص خواهند داد.
فهرست مطالب :
Foreword
Acknowledgments
A Historic Perspective
Preface
Contents
Contributors
Chapter 1: General Introduction to Head and Neck Cancer: Etiology, Symptoms, Diagnosis, Staging, Prevention, and Treatment
Introduction
Epidemiology
Etiology
Tobacco
Alcohol
Alcohol and Tobacco in Combination
Viruses
Immunosuppressive Agents
Diet
Oral Hygiene
Diseases
Oral Microbiota
Socioeconomic Status
Free Radicals
Atmospheric Gases
Occupational Exposures
Other Risk Factors
Symptoms
Diagnosis
Clinical Examination
Imaging
Probing
Tumor Biopsy
Pathology/Immunohistochemistry
Staging System
Prevention
Treatment
Stagewise Treatment for HNC
Early Stage HNC
Stage III/IV Cancers
Metastatic Disease
Perspective
References
Chapter 2: Potentially Malignant Disorders of the Oral Cavity
Introduction
Oral Potentially Malignant Disorders (OPMDs)
Leukoplakia
Erythroplakia
Oral Submucous Fibrosis
Diagnosis and Screening of OPMDs
Noninvasive Techniques
Vital Staining
Light-Based Detection Systems
Chemiluminescence
Tissue Autofluorescence
Photodynamic Techniques
Optical Diagnostic Technologies
Prognostic Molecular Biomarkers
Invasive Detection Techniques
Incisional Biopsy
Oral Brush Cytology (OBC)
Conclusion
References
Chapter 3: Diagnosis and Management of Intraoral Epithelial Dysplasia
Introduction
Aids in the Diagnosis of Oral Dysplasia
Special Emphasis on Other Differential Diagnosis
Proliferative Verrucous Leukoplakia
Lichen Planus
Treatment of Intraoral Dysplasia
How to Avoid the Development of Dysplasia and Oral Cancer
Smoking
Drinking
Chewing
Vitamin Imbalance
Oncogenic Viruses
Surprising Good Side Effects of Medications
Conclusion
References
Chapter 4: Dysphagia in Head and Neck Cancers
Introduction
Surgical Management
Oral Cavity Cancers
Oropharyngeal and Nasopharyngeal Cancers
Laryngeal and Hypopharyngeal Cancers
Radiation Therapy
Assessment of Swallowing Disorders in Head and Neck Cancers
Medical History
Clinical Oral Examination
Instrumental Evaluation
Treatment of Dysphagia in Head and Neck Cancers
Diet Allocation
Compensatory Strategies and Maneuvers
Postural Changes
Compensatory Strategies
Swallowing Exercises
Range of Motion and Strengthening Exercises
Multidisciplinary Team
Conclusion
References
Chapter 5: The Mutational Landscape of Head and Neck Squamous Cell Carcinoma: Opportunities for Detection and Monitoring Via Analysis of Circulating Tumor DNA
Introduction
Mutational Landscape of HNSCC
Comparison of Mutational Landscape of HPV-Positive and HPV-Negative HNSCC
Alterations Associated with Early-Stage HNSCC
Circulating Tumor DNA (ctDNA) in HNSCC
Tumor Detection
Tumor Monitoring
Conclusions and Future Directions
References
Chapter 6: Circulating Biomarkers in Head and Neck Cancer
Introduction
Circulating Tumor DNA and Circulating Tumor Cells
Early Detection
Treatment Selection
Monitoring Treatment Response
Monitoring Minimal Residual Disease
Predicting Metastasis
Circulating Exosomal miRNAs
Salivary Diagnostics
Salivary ctDNA
Salivary miRNA
Salivary Exosomes
Conclusions and Future Perspectives
References
Chapter 7: Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers
Introduction
Networks of Proinflammatory Cytokines, Chemokines, and Growth Factors
Role of Interleukins, Chemokines, and Growth Factors in HNC Pathogenesis
Co-expression of Proinflammatory Factors as Clinical Correlates
Cytokine- and Chemokine-Based Therapies and Their Potentials
NF-κB Pathway and Crosstalk with Other Signaling in Head and Neck Cancers
Classical and Alternative NF-κB Signaling Pathways
Crosstalk of NF-κB Pathway with Other Signaling Pathways
Current Biomarkers and Drug Development Related to NF-κB Pathways
Regulation of Inflammatory Signaling by Ubiquitination and Proteasome
The Ubiquitin System
Ubiquitin-Mediated Regulation of Inflammatory Signaling
The Ubiquitin System in HNSCC: Genomic and Transcriptomic Expression Data
Copy-Number Alteration and mRNA Expression
Somatic Mutations
Targeting the Ubiquitin System in HNSCC
Proteasome Inhibitors
IAP Antagonists
Genomic Signatures and Transcriptomic Landscapes of Proinflammatory and Other Signaling Molecules
Overview of TCGA Project and the Individual Biomarker Paper of HNSCC
Three Major Themes of TCGA Pan-Cancer Atlas Project Include “Cell of Origin,” “Oncogenic Process,” and “Signaling Pathways”
Landscape Characterization of Human Cell Lines Using High-Throughput Technologies
Genome-Wide Gene Perturbation and Interrogation with Functional Analyses
Overall Conclusions and Future Directions
References
Chapter 8: Pain Associated with Head and Neck Cancers
Introduction
Mechanisms of Head and Neck Cancer Pain
Nerve Growth Factor
Endothelin-1
Proteases and Protease-Activated Receptors
How Treatment Modalities Can Cause Pain?
Chronic Pain Pathophysiology
Modulation
New Frontiers
Compounded Analgesic Formulations
Tapentadol
Cebranopadol and NKTR-181
Neurochemistry
Future Perspective
References
Chapter 9: Emerging Trends in Oral Mucoadhesive Drug Delivery for Head and Neck Cancer
Introduction
Histological Structure of the Oral Mucosa and Saliva Components
The Epithelial Layer
The Basement Membrane
The Connective Tissue
Saliva, Mucus, and Mucins
Mucoadhesive Theories
Diffusion Theory
Electronic Theory
Absorption Theory
Fracture Theory
Wetting Theory
Oral Mucoadhesive Drug Delivery System Formulations for Head and Neck Cancer
Solids
Tablets
Wafers
Bioadhesive Microspheres
Semisolids
Films and Patches
Chewing Gum
Ointment or Gel
Liquids or Suspensions
Components of Oral Mucoadhesive Drug Delivery Systems
Drug Substance
Bioadhesive Polymers
Backing Membrane
Plasticizers
Permeation Enhancers
Conclusion
References
Index
توضیحاتی در مورد کتاب به زبان اصلی :
Head and neck cancer (HNC) is a heterogeneous group of cancers that, if combined, represent one of the most common cancer types. Patients with HNC suffer significant morbidity and mortality due to the importance of the structures involved. Over two-thirds of these patients are diagnosed at a late stage, leading to a poor prognosis. Therefore, advancements in early detection and treatment of HNC are crucial. This second volume provides an up-to-date overview of the theoretical background in the field of head and neck cancer (HNC) as well as of the emerging research that is impacting our understanding of this disease. The book begins with a comprehensive review of the epidemiology, etiology, symptoms, diagnosis, and staging of HNC. Next, it covers the essentials of potentially malignant disorders of the oral cavity, an important variety of HNC. Subsequently, it covers the newly emerging research in the field of HNC. The overall goal is to shift towards precision medicine (discussed in detail in Volume I), which will bring individualized clinical benefit to patients with HNC. This second volume of Early Detection and Treatment of Head & Neck Cancers concludes with the topic of chronic pain associated with HNC, including both the mechanisms of pain and the management strategies, and the emerging oral mucoadhesive drug delivery approach for HNC. All HNC surgeons, scientists, residents, and individuals whose lives have been touched by this disease, will recognize the impact pain has upon a patient’s health and his or her recovery trajectory.